miR-150与肺部疾病关系的研究进展
蔡茜1 陈思睿2 朱应群1
1.湖南省长沙市第三医院呼吸与危重症医学科,湖南长沙 410015;
2.湖南省长沙市第三医院急症医学科,湖南长沙 410015
Research progress on the relationship between miR-150 and pulmonary diseases#br#
CAI Qian1 CHEN Sirui2 ZHU Yingqun1
1.Department of Respiratory and Critical Care Medicine, the Third Hospital of Changsha, Hunan Province, Changsha 410015, China;
2.Department of Emergency Medicine, the Third Hospital of Changsha, Hunan Province, Changsha 410015, China
摘要 随着大气污染的加重,环境中有害因子增多,近年来呼吸系统疾病的患病率有着逐年增高的趋势。研究表明,微RNA(miRNA)以调控基因表达的方式参与了机体很多的病理生理过程。miR-150作为miRNA家族中的一员,已被证实与肺癌、急性肺损伤、肺纤维化、肺动脉高压以及慢性阻塞性肺疾病、胸腔积液等相关。miR-150的上调或下调可有效调节这些疾病的生物学过程,提示miR-150与上述疾病的发生、发展及预后密切相关,可能为呼吸系统疾病的诊断和治疗提供新的靶点。本文将针对miR-150与肺部疾病关系的研究进展进行综述。
关键词 :
微RNA ,
肺部疾病 ,
基因调控 ,
miR-150
Abstract :With the aggravation of air pollution and the increase of harmful factors in the environment, the prevalence of respiratory diseases has been increasing year by year in recent years. Studies have shown that micrornas (miRNA) are involved in many pathophysiological processes of the body by regulating gene expression. miR-150 is a member of miRNA family, it has been proven to be associated with lung cancer, acute lung injury, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease, pleural effusion and so on. Up-regulation or down-regulation of miR-150 can effectively regulate the biological process of these diseases, it is suggested that miR-150 is closely related to the occurrence, development and prognosis of the above-mentioned diseases, may provide new targets for the diagnosis and treatment of respiratory diseases. This paper will review the research progress on the relationship between miR-150 and lung diseases.
Key words :
MicroRNA
Lung disease
Gene regulation
miR-150
基金资助: 湖南省卫生健康委科研计划重点课题资助项目(A20182005);
湖南省长沙市自然科学基金资助项目(kq201 4009)。
通讯作者:
朱应群(1967.12-),女,硕士,主任医师;研究方向:慢性阻塞性肺疾病。
作者简介 : 蔡茜(1978.10-),女,硕士,副主任医师;研究方向:慢性阻塞性肺疾病、肺动脉高压。
[1] 陈宏佳,朱应群.与肺动脉高压相关的miRNA的研究进展[J].国际呼吸杂志,2020,40(15):1190-1195.
[2] Shen Z,Tang W,Guo J,et al. miR-483-5p plays a protective role in chronic obstructive pulmonary disease [J]. Int J Mol Med,2017,40(1):193-200.
[3] Yuan K,Orcholski M,Tian X,et al. MicroRNAs:promising therapeutic targets for the treatment of pulmonary arterial hypertension [J]. Expert Opin Ther Targets,2013,17(5):557-564.
[4] Gubrij IB,Pangle AK,Pang L,et al. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension [J]. PLoS One,2016,11(1):e0147827.
[5] 李九龙,刘林,张湘,等.hsa-miR-150-5p的生物信息学分析[J].检验医学与临床,2020,17(13):1805-1810.
[6] Seo SH,Jang MS,Kim DJ,et al. MicroRNA-150 controls differentiation of intraepithelial lymphocytes through TGF-β receptor Ⅱ regulation [J]. J Allergy Clin Immunol,2018, 141(4):1382-1394.
[7] Zhang Z,Wang JM,Li J,et al. MicroRNA-150 promotes cell proliferation,migration,and invasion of cervical cancer through targeting PDCD4 [J]. Biomed Pharmacother,2017,97:511-517.
[8] Siegel RL,Miller KD. Cancer statistics,2018 [J]. CA Cancer J Clin,2018,68(1):7-30.
[9] 张静雯,孙亚娇.miR-150在肺癌细胞中表达变化及其对细胞增殖能力的影响和机制[J].山东医药,2019,59(26):5-8.
[10] Jiang K,Shen M,Chen Y,et al. miR-150 promotes the proliferation and migration of non-small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway [J]. Oncol Rep,2018,40(2):943-951.
[11] 李晓燕,张勇,张丽娜,等.PTEN、LKB1及PI3K在非小细胞肺癌中的表达及意义[J].解剖科学进展,2019,25(5):575-578,582.
[12] Wu Z,Li W,Li J,et al. Higher expression of miR-150-5p promotes tumorigenesis by suppressing LKB1 in non-small cell lung cancer [J]. Pathol Res Pract,2020,216(11):153-145.
[13] Zhang Y,Chen B,Wang Y,et al. NOTCH3 Over expression and Posttrans criptional Regulation by miR-150 Were Associated With EGFR-TKI Resistance in Lung Adenocarcinoma [J]. Oncol Res,2019,27(7):751-761.
[14] Yin QW,Sun XF,Yang GT,et al. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer [J]. Int J Clin Exp Pathol,2015,8(1):842-846.
[15] Yao MY,Zhang WH,Ma WT,et al. Long non-coding RNA MALAT1 exacerbates acute respiratory distress syndrome by upregulating ICAM-1expression via microRNA-150-5p downregulation [J]. Aging(Albany NY),2020,12(8):6570-6585.
[16] Wei S,Liu Q. Long noncoding RNA MALAT1 modulates sepsis-induced cardiac inflammation through the miR-150-5p/NF-κB axis [J]. Int J Clin Exp Pathol,2019,12(9):3311-3319.
[17] Zhang D,Lee H,Haspel JA,et al. Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis sponging microRNA-150 [J]. FASEB J,2017,31(10):4472-4481.
[18] Li P,Yao Y,Ma Y,et al. MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3 [J]. Int Immunopharmacol,2019,75:105794.
[19] Rajput C,Tauseef M,Farazuddin M,et al. MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury [J]. Arterioscler Thromb Vasc Biol,2016,36(2):380-388.
[20] 蒋萍萍,叶宁,徐宝灵.miR-150在急性呼吸窘迫综合征患者血清中的表达及临床意义[J].临床检验杂志,2021, 39(3):202-205.
[21] Li PB,Yao YF,Ma YZ,et al. MiR-150 attenuates LPS-induced a- cute lung injury viatargeting AKT3 [J]. Int Immunopharmacol,2019,75:105794.
[22] Liang J,Gu S,Mao X,et al. Endothelial Cell Morphology Regulates Inflammatory Cells Through MicroRNA Transferred by Extracellular Vesicles [J]. Front Bioeng Biotechnol,2020,19(8):369.
[23] Li Q,Zhou X,Zhou X. Downregulation of miR-98 contributes to hypoxic pulmonary hypertension by targeting ALK1 [J]. Mol Med Rep,2019,20(3):2167-2176.
[24] Liu H,Tao Y,Chen M,et al. Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2 [J]. Sci Rep,2016,6:24661.
[25] Russomanno G,Jo KB,Abdul-Salam VB,et al. miR-150-PTPMT1 cardiolipin signaling in pulmonary arterial hypertension [J]. Mol Ther Nucleic Acids,2020,4(23):142-153.
[26] Chen M,Shen C,Zhang Y,et al. MicroRNA-150 attenuates hypoxia-induced excessive proliferation and migration of pulmonary arterial smooth muscle cells through reducing HIF-1α expression [J]. Biomed Pharmacother,2017,93:861-868.
[27] Rhodes CJ,Wharton J,Boon RA,et al. Reduced microRNA150 is associated with poor survival in pulmonary arterial hypertension [J]. Am J Respir Crit Care Med,2013, 187(3):294-302.
[28] Xue H,Li MX. MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53:MicroRNA-150 in CS-induced lung inflammation [J]. Hum Exp Toxicol,2018,37(9):920-928.
[29] Wang Y,Xu YM,Zou YQ,et al. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma,tuberculosis,and other benign lesions [J]. Medicine(Baltimore),2017,96(44):e8361.
[30] Kishore A,Navratilova Z,Kolek V,et al. Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis [J]. Respi- rology,2018,23(12):1166-1172.
[1]
刘星宇1 王杰2 石菲3. miR-189对骨形成的影响及作用机制 [J]. 中国医药导报, 2021, 18(36): 23-27.
[2]
李海强 李彦 沈徐宁 蒋红钢. LncRNA TUG1通过miR-145/KIAA1199轴对结直肠癌细胞转移和上皮间质转化的影响 [J]. 中国医药导报, 2021, 18(36): 8-13.
[3]
马兰芳1 曹莉莉1 吴章颖2 汪俊涛1. 异位子宫内膜组织差异miRNAs的生物信息学分析 [J]. 中国医药导报, 2021, 18(36): 81-84,90.
[4]
朱凌霄 张兰 张雪鹏 李昊鑫. miR-145对三阴性乳腺癌细胞增殖、侵袭及转移能力的影响 [J]. 中国医药导报, 2021, 18(32): 22-27.
[5]
孙勇1,2 赵创3 刘志丹1,2. 类风湿关节炎中的外泌体及其作用研究进展 [J]. 中国医药导报, 2021, 18(26): 34-38.
[6]
肖菲 戴欢子▲. 肾间质纤维化动物模型在基因调控实验教学中的应用 [J]. 中国医药导报, 2018, 15(34): 61-64.
[7]
陈雅 叶联华▲ 黄云超. 葡萄球菌生物膜形成影响因素的研究进展 [J]. 中国医药导报, 2017, 14(36): 37-42.
[8]
张奕1,2 张兰英1 欧阳瑶1. Th17/Treg失衡与肺部疾病发病机制的研究进展 [J]. 中国医药导报, 2017, 14(35): 20-24.
[9]
屈潇1 秦环龙2. miR-150在肿瘤发生发展中作用机制研究进展 [J]. 中国医药导报, 2017, 14(32): 19-22.